Literature DB >> 21144964

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Philip Greenland, Joseph S Alpert, George A Beller, Emelia J Benjamin, Matthew J Budoff, Zahi A Fayad, Elyse Foster, Mark A Hlatky, John McB Hodgson, Frederick G Kushner, Michael S Lauer, Leslee J Shaw, Sidney C Smith, Allen J Taylor, William S Weintraub, Nanette K Wenger, Alice K Jacobs, Sidney C Smith, Jeffrey L Anderson, Nancy Albert, Christopher E Buller, Mark A Creager, Steven M Ettinger, Robert A Guyton, Jonathan L Halperin, Judith S Hochman, Frederick G Kushner, Rick Nishimura, E Magnus Ohman, Richard L Page, William G Stevenson, Lynn G Tarkington, Clyde W Yancy.   

Abstract

Mesh：

Substances：

Year:  2010        PMID： 21144964     DOI： 10.1016/j.jacc.2010.09.001

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  404 in total

1.  Statistical Relational Learning to Predict Primary Myocardial Infarction from Electronic Health Records.

Authors:  Jeremy C Weiss; David Page; Peggy L Peissig; Sriraam Natarajan; Catherine McCarty
Journal:  Proc Innov Appl Artif Intell Conf       Date:  2012

2.  Work engagement and high-sensitivity C-reactive protein levels among Japanese workers: a 1-year prospective cohort study.

Authors:  Hisashi Eguchi; Akihito Shimazu; Norito Kawakami; Akiomi Inoue; Akinori Nakata; Akizumi Tsutsumi
Journal:  Int Arch Occup Environ Health       Date:  2014-11-02       Impact factor: 3.015

3.  Prognostic value of cardiovascular CT: is coronary artery calcium screening enough? The added value of CCTA.

Authors:  Erick Alexanderson; Nadia Canseco-León; Fernando Iñarra; Aloha Meave; Damini Dey
Journal:  J Nucl Cardiol       Date:  2012-04-04       Impact factor: 5.952

4.  Prediction of coronary artery calcium progression in individuals with low Framingham Risk Score: the Multi-Ethnic Study of Atherosclerosis.

Authors:  Tochi M Okwuosa; Philip Greenland; Gregory L Burke; John Eng; Mary Cushman; Erin D Michos; Hongyan Ning; Donald M Lloyd-Jones
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

5.  Cardiovascular disease prevention: a basic but evolving goal for medicine.

Authors:  Douglas B Bogart
Journal:  Mo Med       Date:  2011 Nov-Dec

6.  Clinical indications for cardiac computed tomography. From the Working Group of the Cardiac Radiology Section of the Italian Society of Medical Radiology (SIRM).

Authors:  E di Cesare; I Carbone; A Carriero; M Centonze; F De Cobelli; R De Rosa; P Di Renzi; A Esposito; R Faletti; R Fattori; M Francone; A Giovagnoni; L La Grutta; G Ligabue; L Lovato; R Marano; M Midiri; L Natale; A Romagnoli; V Russo; F Sardanelli; F Cademartiri
Journal:  Radiol Med       Date:  2012-04-01       Impact factor: 3.469

7.  Atherosclerosis: Should we use CIMT testing? New insights from Framingham.

Authors:  Matthew Budoff
Journal:  Nat Rev Cardiol       Date:  2011-09-20       Impact factor: 32.419

Review 8.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

9.  The role of radionuclide myocardial perfusion imaging for asymptomatic individuals.

Authors:  Robert C Hendel; Brian G Abbott; Timothy M Bateman; Ron Blankstein; Dennis A Calnon; Jeffrey A Leppo; Jamshid Maddahi; Matthew M Schumaecker; Leslee J Shaw; R Parker Ward; David G Wolinsky
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

Review 10.  Headed in the right direction but at risk for miscalculation: a critical appraisal of the 2013 ACC/AHA risk assessment guidelines.

Authors:  Nivee P Amin; Seth S Martin; Michael J Blaha; Khurram Nasir; Roger S Blumenthal; Erin D Michos
Journal:  J Am Coll Cardiol       Date:  2014-05-07       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.